TAP Block for Open Radical Prostatectomy.

Sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre (Other)
Overall Status
Terminated
CT.gov ID
NCT01157546
Collaborator
(none)
25
1
2
31
0.8

Study Details

Study Description

Brief Summary

This is a prospective, double blind, randomized study is proposed in patients undergoing open radical prostatectomy: its objective is to establish whether continuous bilateral TAP blocks would provide adequate perioperative analgesia, decrease opioid consumption, reduce the incidence of opioid-related side effects, and facilitate surgical recovery (in terms of PACU and hospital discharge).

Condition or Disease Intervention/Treatment Phase
  • Procedure: Normal saline via TAP catheters
  • Procedure: Lidocaine via TAP catheters
Phase 1

Detailed Description

Open prostatectomy is a surgical procedure performed by urologists to excise the prostate. This is achieved by a 10-cm vertical incision starting below the umbilicus and reaching the pubic area. Patients are hospitalized for 3-4 days: one of the criteria for safe discharge includes Visual Analogue Scale (VAS) for pain below 3 at rest. For postoperative pain control, patients receive patient-controlled opioid analgesia (PCA) with morphine. The average amount of morphine used in the first 24 h varies between 30 and 50 mg. Although this technique is widely used, side effects (sedation, ileus, pruritus) are commonly encountered with opioid administration. Thus alternative analgesic techniques such as epidural analgesia and wound infiltration have been used with some success. However adverse events have also been reported with these techniques (lower limb motor block with epidural; infection wound infiltration).

In the last 10 years, a new technique, the transversus abdominis plane (TAP) block, which anesthetizes the thoracolumbar nerves (intercostal, subcostal and first lumbar nerves), has been described. The thoracolumbar nerves provide sensory innervation to the anterolateral abdominal wall. The traditional technique for TAP blocks is performed with a blunt needle in the Triangle of Petit. The latter is delineated caudally by the iliac crest, posteriorly by the latissimus muscle and anteriorly by the external oblique. Two distinct pops can be felt as the needle crosses the fascial extensions of the external oblique and the internal oblique muscle, respectively. Thus the second pop usually signifies that the needle tip has reached the TAP. Although the traditional technique has been used to provide postoperatively analgesia for bowel surgery, hysterectomy and Cesarian Section, the position of the Triangle of Petit varies greatly thus making it difficult to palpate in obese patients. In 2007, there was a study describing an ultrasound-guided technique for TAP blocks: these authors advocated using ultrasonography to locate the TAP along the mid-axillary line above the iliac crest. This ultrasound-guided technique has been subsequently used to provide postoperative analgesia for laparoscopic cholecystectomy, appendicectomy and Cesarian Section. This technique has been shown to spare opioids in the postoperative period therefore facilitating an accelerated discharge and superior pain relief.

In our institution, the TAP block, either as a single shot or as a continuous catheter infusion, is used for abdominal and urological surgery when epidural blockade is not feasible.

Study Design

Study Type:
Interventional
Actual Enrollment :
25 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Continuous Transversus Abdominis Plane (TAP) Block for Open Radical Prostatectomy. A Double Blind Randomized Study.
Study Start Date :
Aug 1, 2010
Actual Primary Completion Date :
Mar 1, 2013
Actual Study Completion Date :
Mar 1, 2013

Arms and Interventions

Arm Intervention/Treatment
Placebo Comparator: Control

group A (control) will receive a bolus of normal saline (20 mL per side) followed by a continuous infusion of normal saline (7 ml/h per side) via both TAP catheters.The infusions will be started after the bolus doses and continued postoperatively for 48 hours.

Procedure: Normal saline via TAP catheters
A bolus of normal saline (20 mL per side) followed by a continuous infusion of normal saline (7 ml/h per side. The infusions will be started after the bolus doses and continued postoperatively for 48 hours.
Other Names:
  • 0.9% normal saline
  • NSS
  • Experimental: TAP

    group B (TAP) will receive a bolus of lidocaine 1% with epinephrine 1:200 000 (20 mL per side) followed by a continuous infusion of ropivacaine 0.2% (7 mL/h per side) via TAP catheters. The infusions will be started after the bolus doses and continued postoperatively for 48 hours.

    Procedure: Lidocaine via TAP catheters
    A bolus of lidocaine 1% with epinephrine 1:200 000 (20 mL per side) followed by a continuous infusion of ropivacaine 0.2% (7 mL/h per side). The infusions will be started after the bolus doses and continued postoperatively for 48 hours.
    Other Names:
  • Xylocaine
  • Outcome Measures

    Primary Outcome Measures

    1. Postoperative morphine consumption [at 24 hour after surgery]

    Secondary Outcome Measures

    1. Incidence of nausea and vomiting [at 2, 12, 24 and 48 hour after surgery]

    2. VRS for pain at rest, during ambulation and coughing [at 2, 12, 24 and 48 hour after surgery]

    3. Assessment of recovery [at 24 hours after the surgery and every 24 hours until patients are discharged.]

      Assessment of recovery (two-minute walking test, Miles scale) and time out of bed (sitting or walking will be measured every day until hospital discharge.

    4. Postoperative morphine consumption [at 2, 12 and 48 hours after surgery]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    Male
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Age: 18 years and over

    • ASA class 1, 2

    • Elective open radical prostatectomy

    Exclusion Criteria:
    • Any history or signs of cardiac, hepatic and renal failure. Patients with raised serum LFTs and serum creatinine outside normal range

    • Any chronic use of opioid analgesic

    • Morbid obesity (BMI>40)

    • History of allergic reactions to any of the study medications and the medications used for the trial

    • Pregnancy

    • Previous abdominal surgery

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 McGill University Health Centre, Montreal General Hospital Montreal Quebec Canada H3G1A4

    Sponsors and Collaborators

    • McGill University Health Centre/Research Institute of the McGill University Health Centre

    Investigators

    • Principal Investigator: Franco Carli, Professor, McGill University Healt Centre, Department of Anesthesia

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Gabriele Baldini, MD, MSc, Assistant Professor, MD, Assistant Professor, McGill University Health Centre/Research Institute of the McGill University Health Centre
    ClinicalTrials.gov Identifier:
    NCT01157546
    Other Study ID Numbers:
    • GEN-10-012
    First Posted:
    Jul 7, 2010
    Last Update Posted:
    Mar 17, 2015
    Last Verified:
    Mar 1, 2015
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Mar 17, 2015